Wal-Mart's long-standing plans to come to Washington, D.C., are now up in the air. The City Council passed a living wage law that would require the world's largest retailer to pay $12.50 an hour, more than the city's current $8.25 minimum wage.
Biology professor Mitch Aide uses his ears to learn about the frogs, birds and insects that are all around him. This scientist at the University of Puerto Rico is trying to track how animal populations are affected by a world that's under increasing pressure from human activities.
Aide says, "We would like to have five, 10, 20 years of data of how populations are changing."
The Chesapeake Bay once supplied half the world's oyster market. But pollution, disease and over-harvesting have nearly wiped out the population. It's a dire situation that's united former adversaries to revive the oyster ecosystem and industry.
Scientists and watermen have joined forces to plant underwater farms in the bay with a special oyster bred in a lab. Called triploid oysters, they have been selected for attributes like disease tolerance and fast growth.
The Code Switch team came across this blog post by Sam Sanders, our colleague at NPR. We thought it spoke to the resignation so many people felt following Trayvon Martin's shooting. Sam was kind enough to let us share it here.
With Tuesday's bipartisan agreement to let senators vote on seven of President Obama's previously stalled nominations, the Senate proved that the art of compromise isn't dead in Washington, even if it might be severely wounded.
At a small park in Pyne Poynt on the north side of Camden, N.J., kids take practice cuts on the infield dirt and adjust their hats. A small but enthusiastic crowd shouts words of encouragement, but the cheering parents and playful bench-side scuffles only momentarily disguise the troubles in the city. Baggies, vials and hypodermic needles litter the same field where practice is being held.
"Each day, our kids walk past drug sets and open air drug use," says Bryan Morton, the North Camden Little League president.
Sometimes a drug hits cancer hard. Sometimes the cancer cells are unfazed. But it's often hard to know which outcome to expect.
A group of scientists at the National Cancer Institute has spent the last three years turning some mathematical algorithms loose on giant sets of data to better understand the relationship between cancerous cells and cancer drugs.